Request Discount

Digital PCR (dPCR) and Real Time PCR (qPCR) Market (Product Type - Instruments, Reagents and Consumables, and Services; Application - Clinical, Research Institutes, Forensic Labs, and Other Applications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

  • Published : July, 2019

  • Rep Id : HC0582

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on digital PCR (dPCR) and real time PCR (qPCR) market provides an in-depth analysis of segments and sub-segments in the global as well as regional digital PCR (dPCR) and real time PCR (qPCR) market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional digital PCR (dPCR) and real time PCR (qPCR) market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global digital PCR (dPCR) and real time PCR (qPCR) market. According to the report, the global digital PCR (dPCR) and real time PCR (qPCR) market are projected to grow at a CAGR of 7.5% over the forecast period of 2020-2026.


digital PCR (dPCR) and real time PCR (qPCR) marketA

 

Market Insight

Digital PCR (dPCR) and Real-time PCR (qPCR) market were estimated to grow at a healthy rate in the pre-pandemic period. However, the outbreak of COVID-19 has caused the demand for Digital PCR (dPCR) and Real Time PCR (qPCR) to increase drastically. The real time or conventional RT–PCR is used to detect COVID-19 as the virus only contains RNA. Therefore, Digital PCR (dPCR) and Real Time PCR (qPCR) were very instrumental in the development of these diagnostic tests, tools, kits. Digital PCR (dPCR) and Real Time PCR (qPCR) are also among the most important tools to slow and reduce the spread and impact of the coronavirus. As the pandemic continues, even greater demand will be witnessed in all parts of the world.

 

The COVID-19 pandemic spread across all 7 continents with a high rate of transmission of COVID-19. Currently, Real Time PCR (qPCR) is considered a gold standard for the diagnosis of COVID-19. They are intended for the in vitro qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lower respiratory tract fluids such as bronchoalveolar lavage, sputum, tracheal aspirate, and upper respiratory tract fluids such as nasopharyngeal and oropharyngeal swabs from individuals suspected of COVID-19 by their healthcare provider. RT-PCR tests are very specific and sensitive. These kits can detect as little as one virus particle in swabs taken from inside the mouth or nose. In addition, most countries relied on RT-PCR tests initially because these were the fastest to develop. However, several false-negative rates of qPCR tests are reported, therefore, digital PCR (dPCR) is being highly used to diagnose COVID-19 as its results are more accurate than Real Time PCR (qPCR). The market for Digital PCR (dPCR) and Real Time PCR (qPCR) catapulted after the advent of the COVID-19 pandemic as these both are important methods of diagnosis of COVID-19. These methods are proving very useful in the evaluation of anti-COVID-19 drugs, in the detection of the COVID-19 mutations, dynamically monitoring the disease progression, and monitoring the concentration of the COVID-19 virus in the environment. Therefore the demand in the market for these tests is anticipated to remain high until the outbreak of COVID-19 is completely over.

 

Apart from its use in COVID-19 detection, the rising number of genetic diseases such as chromosomal abnormalities, single gene defects, multifactorial problems, teratogenic problems and increasing diagnosis rate of nucleic acid impurities will also increase the demand for Digital PCR (dPCR) and Real-time PCR (qPCR). Digital PCR (dPCR) and Real-time PCR (qPCR) helps to monitor the genetic makeup of the human by knowing the genetic sequence. This information is helpful in genetic disease identification and mutations that can become the cause of disease in the future. Unlike other genetic analyzers, digital PCR and real-time PCR works with the benefit of real-time detection of genetic material such as DNA or RNA. A growing number of genetic disorders globally is also one of the major factors driving the Digital PCR (dPCR) and Real-time PCR (qPCR) market. According to the WHO, it is estimated that over 10,000 human diseases are known to be monogenic. Monogenic diseases result from modifications in a single gene occurring in all cells of the body, though the occurrence of monogenic diseases is rare, they affect millions of people worldwide. Moreover, increasing research and development activities for the new drug development has also fuelled the Digital PCR (dPCR) and Real-time PCR (qPCR) market. By knowing the genetic sequence of an organism’s scientists can alter the sequence to produce recombinant drugs. Furthermore, the increasing demand for host cell DNA or RNA impurities in the sample or biological drug has also contributed to the growth of the market. On the other hand, the high cost associated with instruments and reagents can hamper the growth of the market. However, the rising demand for genetic analysis globally provides a better opportunity for the growth of the market.

 

Geographically, North America dominates the global market and is expected to keep its dominance over the forecast period, followed by Europe. Advanced healthcare facilities and increasing research and development activities are supporting the growth of the market in these regions. The Asia-Pacific is a high potential market for Digital PCR (dPCR) and Real-time PCR (qPCR). The presence of countries with the Highest Population such as China and India and the high transmission rate of SARS-CoV-2 in these countries are major factors responsible for the high growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) market in the Asia Pacific region. Furthermore, the rising prevalence of genetic diseases and heavy investments by major pharma players for research and developments will also contributing towards a sustained growth of the market in this region.  Moreover, regions such as Africa and South America are also expected to witness high demand for digital and real-time PCR as they are the most widely used diagnostic tests for detecting diseases such as Ebola, African swine fever, and foot-and-mouth disease which are widely prevalent in these regions


Segment Covered

The report on global digital PCR (dPCR) and real time PCR (qPCR) market covers segments such as product type, and application. On the basis of product type, the sub-markets include instruments, reagents and consumables, and services. On the basis of application, the sub-markets include clinical, research institutes, forensic labs, and other applications.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, F. Hoffman-La Roche Ltd., Merck KGaA, Qiagen N.V., Takara Bio, Inc., Thermo Fisher Scientific, Inc., and Other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of digital PCR (dPCR) and real time PCR (qPCR) market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount